SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (487)5/16/2012 8:00:21 PM
From: ghmm  Read Replies (1) of 508
 
Speaking of Fibrogen here is a link to the changes in their Phase 2 study (just got the update on my RSS feed). I don't know when they started/will start cohort 2. I never count on the clinicaltrials.gov completion date (they have 12/2013). So assuming they wait for that to finish before pursing a Phase 3 and we're looking at several years behind ITMN.

If it wasn't open label and the results continued to be promising maybe they'd have a shot with exceptional Phase 2 but that seems unlikely.

EDIT forgot link
clinicaltrials.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News